Ivenix nabs $42 mln

By Iris Dorbian — 5 months ago

Ivenix Inc, which is developing an infusion management system for hospitals, has secured $42 million in funding. WuXi Healthcare Ventures led the round with participation from investors that included Cardinal Partners, CICA Inc, Easterly Ventures, Fidelity Biosciences and SCP Vitalife Partners. Leerink Partners served as the placement agent.

Continue

VC-backed Teladoc debuts IPO

By Iris Dorbian — 7 months ago

Telehealth platform Teladoc has raised $156.75 million for its IPO after pricing its 8.25 million shares (originally planned at 7 million) at $19 per share. The stock began trading Wednesday on the New York Stock Exchange under the ticker symbol “TDOC.” J.P. Morgan Securities LLC and Deutsche Bank Securities Inc are the lead underwriters. Teladoc’s backers include Icon Ventures, FLAG Capital Management, Greenspring Associates, QuestMark Partners, Cardinal Partners, HLM Venture Partners, Kleiner Perkins Caufield & Byers, New Capital Partners and Trident Capital.

Continue

VC-backed Teladoc sets IPO pricing terms

By Iris Dorbian — 8 months ago

Dallas-based telehealth platform Teladoc has priced its IPO of 7 million shares at between $15 and $17 per share. The company plans on trading the stock on the New York Stock Exchange under the ticker symbol “TDOC.” J.P. Morgan Securities LLC and Deutsche Bank Securities Inc are serving as the lead underwriters. Teladoc’s backers include Icon Ventures, FLAG Capital Management, Greenspring Associates, Mellon, QuestMark Partners, Cardinal Partners, HLM Venture Partners, Kleiner Perkins Caufield & Byers, New Capital Partners and Trident Capital.

Continue

LifeIMAGE picks up $17.5 mln

By Iris Dorbian — 9 months ago

Cambia Health Solutions has led a $17.5 million funding round for LifeIMAGE. Cardinal Partners, Galen Partners, Long River Ventures, Mass Ventures and Partners Innovation Fund also participated in the round. Oppenheimer & Co. Inc was the placement agent. Headquartered in Newton, Massachusetts, LifeIMAGE is a medical image exchange platform provider.

Continue

VC-backed aTyr Pharma rolls out IPO

By Iris Dorbian — 9 months ago

San Diego-based biotherapeutics company aTyr Pharma Inc has debuted its IPO after pricing its 5.36 million shares at $14 per share. The stock began trading Thursday on the NASDAQ under the ticker symbol “LIFE.” J.P. Morgan Securities LLC and Citigroup Global Markets are serving as the lead underwriters. The company’s backers include Alta Partners, Cardinal Partners, Domain Associates, Polaris Partners, Sofinnova Ventures, T. Rowe Price Associates Inc, Federated Investors Inc, Deerfield, Rock Springs Capital Management, EcoR1 Capital and Sphera Global Healthcare.

Continue

VC-backed aTyr files for IPO

By Iris Dorbian — 10 months ago

San Diego-based biotherapeutics company aTyr Pharma Inc has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be set. The company plans on trading its stock on the NASDAQ under the ticker symbol “LIFE.” J.P. Morgan Securities LLC and Citigroup Global Markets Inc will serve as the lead underwriters. The company’s backers include Alta Partners, Cardinal Partners, Domain Associates, Polaris Partners, Sofinnova Ventures, T. Rowe Price Associates Inc, Federated Investors Inc, Deerfield, Rock Springs Capital Management, EcoR1 Capital and Sphera Global Healthcare.

Continue

Cureatr expands board of directors with new addition

By Iris Dorbian — 2 years ago

Cureatr, a mobile care coordination solution for healthcare providers, has added Carl Byers to its board of directors. The appointment is effective immediately. Byers is a venture partner at Fidelity Biosciences, a VC fund. Cureatr’s backers include Cardinal Partners, Milestone Venture Partners, JMI Services and the Partnership Fund for New York City.

Continue

Cureatr raises $5.7mln Series A

By Angela Sormani — 2 years ago

Cureatr, a mobile care coordination solution for healthcare providers, has secured $5.7 million in Series A financing. The funding round was co-led by Cardinal Partners and Milestone Venture Partners with JMI Services and the Partnership Fund for New York City participating.

Continue

Cureatr inks $5.7m Series A

By Angela Sormani — 2 years ago

Cureatr, a mobile care coordination solution for healthcare providers, has secured $5.7 million in Series A financing. The funding round was co-led by Cardinal Partners and Milestone Venture Partners with JMI Services and the Partnership Fund for New York City participating.

Continue

Awarepoint Picks up $14M

By Jonathan Marino — 4 years ago

Awarepoint Corp., the real-time location system services provider for healthcare clients, has added $14 million in funding. Heritage Group led the round and was joined by Kleiner Perkins Caufield & Byers, Cardinal Partners, Venrock, Jafco Ventures, Avalon Ventures, New Leaf Venture Partners and Top Tier Capital Partners. PRESS RELEASE: Awarepoint Raises $14 Million in Additional […]

Continue

aTyr Pharma Appoints Board Member

By Angela Sormani — 4 years ago

Protein therapeutics company aTyr Pharma has appointed R. Alan Ezekowitz to aTyr’s Therapeutic advisory board. Physician scientist Dr. Ezekowitz has led various research and development programs at Merck. The privately-held biotech company was founded by The Scripps Research Institute Professor Paul Schimmel and is backed by life sciences investors Alta Partners, Cardinal Partners, Domain Associates […]

Continue

Medley Health Raises $20M Series A to Help Doctors Manage Practices

By Lawrence Aragon — 4 years ago

Medley Health, which provides physician practice management services, announced Wednesday that it had raised $20 million in Series A financing from Cardinal Partners, Technology Partners and Vivo Ventures. The Dublin, Calif.-based company says it will use the capital to expand its physician partnerships, invest in its practice management services and boost staffing. “As a physician, I understand firsthand […]

Continue

Young Verastem Files for an IPO

By PEHub Administrator — 4 years ago

Verastem, a Cambridge, Mass.-based biopharmaceutical company focused on developing cancer-fighting drugs, has filed a registration statement with the SEC to go public. The number of shares and price range have not yet been determined. The 15-month-old company has raised $48 million in venture financing since its founding, including from Advanced Technology Ventures, MPM Capital, Bessemer […]

Continue

Teladoc Snaps Up $18.6M

By PEHub Administrator — 4 years ago

KPCB led a $18.6 million funding in Teladoc, the Dallas-based telehealth provider, joining existing investors Cardinal Partners, HLM Venture Partners, Trident Capital and New Capital Partners. Dana Mead from KPCB worked on the transaction for the VC.

Continue

Kleiner Perkins Leads $27 Mln Financing Round for Awarepoint

By Luisa Beltran — 4 years ago

Awarepoint Corp. said Wednesday that it has closed $27 million in Series F financing. Kleiner Perkins Caufield & Byers led the round while Top Tier Capital Partners also invested. Existing investors Cardinal Partners, Venrock, and Jafco Ventures also participated. Awarepoint, of San Diego, provides real-time location systems for U.S. hospitals.

Continue

Verastem Nabs $32M in Series B

5 years ago

Boston-based Verastem has raised $32 million in Series B financing, only eight months after wrapping up a $16 million Series A round. Advanced Technology Ventures and Astellas Venture Management led the Series B, and were joined by all previous investors: Longwood Founders Fund, Bessemer Venture Partners, Cardinal Partners and MPM Capital. The money will support ongoing research and development. Verastem is and developing drugs to treat breast and other cancers by targeting cancer stem cells.

Continue

aTyr Pharma Lands $23M Round Led by Domain Associates

By PEHub Administrator — 5 years ago

San Diego-based biopharmaceutical startup aTyr Pharma has just raised $23 million in Series C financing from Domain Associates, Alta Partners, Cardinal Partners and Polaris Ventures. According to the company, the money will be used to accelerate the development of its preclinical pipeline and to advance its drug candidates into clinical trials.  PRESS RELEASE:  aTyr Pharma, a physiocrine therapeutics company, today […]

Continue